monitoring for metabolic acidosis in patients taking topiramate (Topamax)

February 2004

Janssen-Ortho just issued a new warning about monitoring for metabolic acidosis in patients taking topiramate (Topamax).

There have been 5 cases already reported in Canada.

This is not limited to patients taking Topamax for seizures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

home blood pressure monitors
Migraine new triptan for migraines called Axert (almotriptan)
Anticoagulants blood clots after long plane flights
Health Canada just approved Zyprexa IM, the first INJECTABLE atypical antipsychotic
monitoring for metabolic acidosis in patients taking topiramate (Topamax)
Ophthalmology two new eye drops to treat glaucoma, Combigan and Alphagan P
Restolate, a new OTC multivitamin containing folic acid and B vitamins
Unexplained muscle or bone pain might be due to vit D deficiency
guidelines for treating atrial fibrillation focus more on controlling heart RATE
Obesity & Weight Loss Xenical being used for weight control in ADOLESCENTS
Dermatology patients work up a sweat after taking ketoconazole for tinea versicolor
Hematology & Oncology Iressa, a new oral drug for lung cancer
Women's Health Evra, the first contraceptive PATCH
Women's Health whether Viagra works in WOMEN
Practice new drugs approved by Health Canada